Publication | Open Access
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer
524
Citations
41
References
2016
Year
These preclinical results indicate that targeted inhibition of IL-6 may enhance the efficacy of anti-PD-L1 in PDAC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1